Carnitine palmitoyltransferase II deficiency

Carnitine palmitoyltransferase II deficiency, sometimes shortened to CPT-II or CPT2, is an autosomal recessively inherited genetic metabolic disorder characterized by an enzymatic defect that prevents long-chain fatty acids from being transported into the mitochondria for utilization as an energy source. The disorder presents in one of three clinical forms: lethal neonatal, severe infantile hepatocardiomuscular and myopathic.

Source: Wikipedia — Carnitine palmitoyltransferase II deficiency (CC BY-SA 4.0)

Carnitine palmitoyltransferase II deficiency

Carnitine palmitoyltransferase II deficiency, sometimes shortened to CPT-II or CPT2, is an autosomal recessively inherited genetic metabolic disorder characterized by an enzymatic defect that prevents long-chain fatty acids from being transported into the mitochondria for utilization as an energy source. The disorder presents in one of three clinical forms: lethal neonatal, severe infantile hepatocardiomuscular and myopathic.

Source: Wikipedia "Carnitine palmitoyltransferase II deficiency" · CC BY-SA 4.0

Share this article: X · Bluesky
Privacy Policy